l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells
Luca Sancineto(University of Perugia), Claudio Santi(University of Perugia), Aleksandra Synowiec(Jagiellonian University), Carmine Ostacolo(University of Naples Federico II), Agnieszka Dąbrowska(Jagiellonian University), Krzysztof Pyrć(Jagiellonian University), Paweł Botwina(Jagiellonian University), Nunzio Iraci(University of Messina), David Ortega-Alarcón(Universidad de Zaragoza), Ana Jiménez-Alesanco(Universidad de Zaragoza), Laura Ceballos-Laita(Universidad de Zaragoza), Adrián Velázquez‐Campoy(Universidad de Zaragoza), Anna Kula(Jagiellonian University), Sonia Vega, Olga Abián(Universidad de Zaragoza), Silvia Moretti(University of Perugia)
Cited by 10
Related Papers
Fluorine‐Containing Drugs Approved by the FDA in 2018
|Chemistry - A European Journal|2019|446
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
|Clinical Microbiology Reviews|2021|219
IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
|PLoS Pathogens|2014|164
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
|Nature Communications|2017|129
APOBEC3-mediated restriction of RNA virus replication
|Scientific Reports|2018|129